Société Algérienne des Affaires Réglementaires et de Pharmaco-économie
Informations de contact, plan et itinéraire, formulaire de contact, heures d'ouverture, services, évaluations, photos, vidéos et annonces de Société Algérienne des Affaires Réglementaires et de Pharmaco-économie, Algiers.
The Algerian Society for Regulatory Affairs & Pharmacoeconomics (SAARPE) is a non-profit scientific organization, created in Algiers on 26th of October 2015, under the provisions of the Law No. 12-06 related to Associations. La SAARPE
SOCIETE ALGERIENNE DES AFFAIRES REGLEMENTAIRES ET DE PHARMACO-ECONOMIE est une association nationale savante à but non lucratif comptant parmi ses membres, pour ne citer que ceux-là, des pharmaciens, des praticiens, des économistes, des gestionnaires et opérateurs économiques du secteur de la Santé. Créée à Alger et ayant officiellement obtenu son agrément le 06 Mai 2016, la SAARPE a pour Mission de former, d’informer et de communiquer sur les affaires réglementaires et la pharmaco-économie.
08/12/2020
Global equitable access to vaccines in low- and lower-middle-income countries has been estimated to generate economic benefits of at least US$ 153bn in 2020–21, and US$ 466bn by 2025, in 10 major economies (Canada, France, Germany, Japan, Qatar, South Korea, Sweden, UAE, UK and USA), according to Eurasia Group's new report commissioned by the Bill & Melinda Gates Foundation.
This is more than 12 times the US$ 38bn estimated total cost of the Access to COVID-19 Tools (ACT) Accelerator, led by WHO, and aiming to support the development and equitable distribution of the tests, treatments and vaccines the world needs to fight COVID-19.
: Official decrees defining conditions for granting Marketing Authorization related to Drug and Medical Devices, as well as Inter-Ministerial Pricing Committee organization and functioning rules have just been published in the Official Gazette No 69 dated of November 22nd, 2020.
05/12/2020
The first COVID-19 vaccine for the UK, developed by Pfizer/BioNTech, has today been given approval for use following a thorough a "rolling review" carried out by the Medicines and Healthcare products Regulatory Agency (MHRA).
Interested by regulatory affairs and/or health economics fields? Join the SAARPE today, and receive a complementary hard copy of "The Pharma Legal Handbook Algeria".
Vous êtes intéressés par le domaine des affaires réglementaires et/ou de l’économie de santé ? Rejoignez la SAARPE dès aujourd’hui et recevez un exemplaire gratuit de l’ouvrage "The Pharma Legal Handbook Algeria".
The aforementioned strategy is based on four specific pillars, which include legislative and non-legislative action:
1- Ensuring access to affordable medicines for patients, and addressing unmet medical needs (e.g. in the areas of antimicrobial resistance, rare diseases);
2- Supporting competitiveness, innovation and sustainability of the EU’s pharmaceutical industry and the development of high quality, safe, effective and greener medicines;
3- Enhancing crisis preparedness and response mechanisms, diversified and secure supply chains, address medicines shortages;
4- Ensuring a strong EU voice in the world, by promoting a high level of quality, efficacy and safety standards.
12/11/2020
To all Virtual ISPOR Europe 2020 registered attendees, don't miss the ISPOR Arabic Network's Discussion Group exploring the "Effect of Public and Private Partnership in Healthcare Financing to Improve Health Outcomes"...
Link to join the 1-hour live discussion (November 17, 2020: 18:15-19:15 CET): https://lnkd.in/eU-2ZaT
Group Discussions are a new, two-part content type for ISPOR events: an on demand, pre-recorded session to be released before the live conference dates, and a follow-up hour-long live discussion during the live conference dates. The expectation for attendees is that they watch the on-demand content before the meeting, and then participate in a live discussion of the on-demand sessions during the conference.
25/10/2020
"PHARMACIST FORUM" [Invitation].
Topic: Health Technology Assessment & Budget Impact Analysis.
Date: Saturday, October 10th, 2020.
Time: 16:00-18:00 (GMT+1).
Language: French.
Link for registration: https://us02web.zoom.us/webinar/register/WN_AS1jsBgpTKybUd8LFrZPCQ
ALGER - Le Premier ministre, Abdelaziz Djerad, a présidé mercredi par visioconférence une réunion du Gouvernement durant laquelle ont été examinés des...
Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Société Algérienne des Affaires Réglementaires et de Pharmaco-économie publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.
Contacter La Pratique
Envoyer un message à Société Algérienne des Affaires Réglementaires et de Pharmaco-économie:
The Algerian Society for Regulatory Affairs & Pharmacoeconomics (SAARPE) is a non-profit scientific organization, created in Algiers on 26th of October 2015, under the provisions of the Law No. 12-06 related to Associations.
The purpose of the SAARPE is related to providing continuing education, and information for healthcare professionals, using Pharmacoeconomics tools for production of scientific data that can advise healthcare decision-makers in order to provide optimal services at lower costs.
The missions of SAARPE encompass:
(1) To participate in the promotion of scientific research in the field of Pharmacoeconomics and the development of the Health Technology Assessment (HTA) as a discipline in Algeria in collaboration with the public authorities.
(2) To organize conferences, seminars, and scientific days as part of continuing education of the healthcare professionals in the field of Pharmaceutical Regulations & Pharmacoeconomics in coordination with the national health authorities.
(3) To provide training sessions and workshops for healthcare professionals in all the branches of health to improve their knowledges and skills in the field of Pharmaceutical Regulatory Affairs & Pharmacoeconomics.
(4) To create an electronic portal for the publication of news, results of scientific works and conferences, both national and international ones, in relation with Pharmaceutical Regulatory Affairs & Pharmacoeconomics.
(5) To build a digital database of books, journals and articles related to Pharmaceutical Regulatory Affairs & Pharmacoeconomics that will be made available to the healthcare professionals.
(6) To participate in different scientific events both in Algeria and abroad in relation with the purpose of the SAARPE.
!["PHARMACIST FORUM" [Invitation].Topic: Health Technology Assessment & Budget Impact Analysis.Date: Saturday, October 10t...](https://img5.findhealthclinics.com/669/969/1004464116699699.jpg)
!["PHARMACIST FORUM" [Invitation].Topic: Innovative Pharma Contracting.Date: Saturday, October 24th, 2020.Time: 16:00-17:3...](https://img3.findhealthclinics.com/386/357/999491993863578.jpg)
!["PHARMACIST FORUM" [Invitation].Topic: Pharmacovigilance, Biologics & Biosimilars.Date: Saturday, October 17th, 2020.Tim...](https://img4.findhealthclinics.com/090/536/995740790905365.jpg)
